(5-cyano-2-thiazolyl)amino-4-pyridine tyrosine kinase inhibitors
US6875767B2 · kind B2 · utility
15Cited by
12References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 19, 2002 |
| Grant date | Apr 5, 2005 |
| Priority date | — |
| Expiry date | Aug 5, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds having the formula I: which inhibit, regulate and/or modulate tyrosine kinase signal transduction, compositions which contain these compounds, and methods of using them to treat tyrosine kinase-dependent diseases and conditions. The compounds of the present invention are useful in treating angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, inflammatory diseases, and the like in mammals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.